Company
Headquarters: Castel San Pietro, Switzerland
Employees: 1,246
CHF3.12 Billion
CHF as of Jan. 1, 2026
US$3.93 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CHF601.6 M |
| EBITDA | CHF152.5 M |
| Gross Profit TTM | CHF406.7 M |
| Profit Margin | 14.69% |
| Operating Margin | 17.61% |
| Quarterly Revenue Growth | 19.20% |
Medacta Group SA has the following listings and related stock indices.
Stock: SIX: MOVE wb_incandescent